Skip to content
MS
Single-pathway Pathway metabolite unreviewed

Fumarylacetoacetate

0
Pathways
0
Categories
0
As substrate
0
As product

Reactions involving Fumarylacetoacetate

Every recorded step where this molecule takes part

Showing all 2 reactions.

Recent literature

Europe PMC · fetched just now · sorted by publication date

  1. 1
  2. 2
    An optimized engineered bacterium for tyrosinemia type 1 therapy: A multi-species preclinical study.

    Gu P, Zhao Y, Hu J, Tian Y, Zhao L, Ren J, Yang Q, Li J, He W, Guo J, Chen P. · 2026-06-02

    unreviewed
  3. 3
    RNA-seq reveals differentially expressed genes involved in catecholamine synthesis and metabolism in the hypothalamus affecting divergent residual feed intake in slow-growing Korat chickens.

    Sinpru P, Jantasaeng O, Pasri P, Kamkrathok B, Pengsanthia S, Porter TE, Molee W, Molee A. · 2026-05-08

    open access unreviewed
  4. 4
    Disrupting fumarylacetoacetate hydrolase by stratified nanoplatforms orchestrates metabolic-immune reprogramming and prevents post-ablation HCC relapse.

    Hong Z, Liu X, A R, Chen Z, Wu Q, Fu J, Guan X, Wang C, Wang X, Jiang S, Li B, Wang Z, Zhang L, Meng X, Cui Y… · 2026-07-14

    unreviewed
  5. 5
    Morphological characterization of a novel model of steatohepatitis in the <i>FAH</i><sup><i>-/-</i></sup> pig.

    Wilken SN, Felgendreff P, Minshew A, Ahmadzada B, Hosseiniasl SM, Kazeminia S, Ezenekwe K, Patil A, Park BU, … · 2026-01-17

    unreviewed
  6. 6
    A DPHV-liver module recapitulates AML infiltration and chemotherapy-induced hepatotoxicity with translational utility.

    Deng B, Ma Y, Huang W, Xian X, Ding Y, Lu Y, Yang Y, Guo W, Mao L, Wang X, Jiang E, Ma X, Huang P. · 2026-06-12

    open access unreviewed
  7. 7
    Targeting GSTZ1 Sensitizes KRASG12C-Mutant Lung Cancer Cells by Overcoming Glutathione and Glycolysis Pathway Rewiring.

    Liao Y, Li X, Liu M, Fernandes VC, Duckett D, Haura EB, Monastyrskyi A, Rix U. · 2026-06-01

    open access unreviewed
  8. 8
    Rapid multiplex liver gene-editing in mice using adeno-associated virus 8 or lipid nanoparticles.

    Wu D, Bolt I, Tolenaars DW, Duijst S, In Het Panhuis W, Hofstraat SRJ, Zwolsman R, van der Meel R, Paulusma C… · 2026-03-18

    open access unreviewed
  9. 9
  10. 10
    Therapeutic adenine base editor with minimized off-target effects.

    Sun Y, Yan N, Feng H, Lu H, Zuo Z, Zhou C, Zuo E. · 2026-06-01

    cited 1× open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.